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Factor XI deficiency is rare but may cause life-threatening bleeding during the perioperative period. The clinical
manifestation of factor XI deficiency is characterized by bleeding tendency. This unpredictable bleeding tendency
makes anesthetic management difficult. We report a case of a partial duodenectomy in a patient with factor
XI deficiency. The patient was scheduled for duodenectomy because of a duodenal tumor. When checked for
coagulation before surgery, the patient was found to have a remarkably prolonged activated partial thrombin
time, and further investigation revealed factor XI deficiency. Fresh frozen plasma was transfused before surgery, and
general anesthesia and peripheral nerve block were performed. In the present case of factor XI deficiency, supplementation
with clotting factor and proper anesthetic management were important to prevent severe complications.
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Factor XI is a plasma glycoprotein that participates in
the intrinsic pathway of the blood coagulation cascade.
Factor XI deficiency is a rare, autosomal recessive disorder
present in 1:1,000,000 individuals [1]. In hemophilia A
and B, the bleeding tendency is clearly related to factor
level; however, a deficiency of factor XI results in unusual
coagulopathy, with a poor correlation between the
measured factor XI level and bleeding tendency [2].
The unclear presentation of factor XI deficiency re-
sults in difficulties in anesthetic management of pa-
tients with this disorder. In this report, we present a
patient with factor XI deficiency who underwent duo-
denectomy for a duodenal tubulovillous adenoma.Case presentation
A 75-year-old woman (46.2 kg, 153.7 cm tall, and
American Society for Anesthesiologists physical status II)
was scheduled for a partial duodenectomy. She provided
written informed consent for participation and publica-
tion. Her previous surgical history included ovariectomy* Correspondence: yufune@r4.dion.ne.jp
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the Creative Commons license, and indicate ifunder general anesthesia at the age of 38 years, for which
the surgical and anesthetic procedures were uneventful.
She also had a history of hypertension, which was treated
with angiotensin II receptor blockers. She had no other
past medical history. At presentation, she was not taking
any herbal preparations or anticoagulants. She had no
family history of bleeding tendency.
Four months prior to her surgery, she developed epi-
gastric pain and an endoscopic examination revealed a
duodenum tumor; she was scheduled for a partial duo-
denectomy. Laboratory findings on admission were as
follows: normal electrocardiogram and chest X-ray,
hemoglobin 13.4 g/dL, platelet count 21.5 × 104 μL, and
the coagulation tests showed prolonged activated partial
thromboplastin time (APTT 89.7 s); however, the pro-
thrombin time and the international normalized ratio of
prothrombin time were normal (PT 10.3 s, PT-INR 1.01).
Hemophilia A and B are usually considered first, especially
in males, whenever a prolonged APTT is noted; however,
our female patient had no family history of bleeding.
Further investigation revealed severely deficient levels
of factor XI, and factor XI deficiency was diagnosed.
The levels of activity of her factors VIII, IX, XI, and
XII are shown in Table 1.is distributed under the terms of the Creative Commons Attribution 4.0
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Table 1 Coagulation factor levels





Table 2 The levels of exudate from the surgical drain
POD 0 1 2 3 4 5 6 7
Exudate (mL) 95 140 134 162 178 141 120 25
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deficiencies are at risk of bleeding from the surgical site,
and anesthetic management is one of the most import-
ant concerns for the attending anesthesiologist. To avoid
massive bleeding during the surgical procedure, 4 units
of fresh frozen plasma (FFP) was transfused (in Japan,
the estimated volume per unit of FFP is 120 mL/unit)
1 day prior to the surgery. We performed another co-
agulation test immediately before entering the operating
room, and her APTT level improved to 36.2 s.
In our facility, epidural anesthesia is the first choice of
analgesia for open upper abdominal surgery. However,
because the patient had a potential risk of epidural
hemorrhage, we avoided epidural anesthesia and selected
ultrasound-guided subcostal transversus abdominis
plane (TAP) block with rectus sheath block. General
anesthesia was induced by target-controlled infusion of
propofol at a target plasma concentration of 3 μg/mL.
Fifty milligrams of rocuronium was administered after
loss of response to verbal commands. Remifentanil was
initiated at a rate of 0.3 μg/kg/min, and propofol was ad-
justed to maintain a bispectral index of 40–60. Subcostal
TAP block with rectus sheath block was performed in
the supine position. After skin preparation with 0.5 %
chlorhexidine, the ultrasound probe was placed parallel
to the subcostal margin near the xiphoid process, the
needle was advanced to the TAP, and 20 mL of 0.25 %
levobupivacaine was administered to the TAP. After sub-
costal TAP block, the rectus muscle was imaged with
the ultrasound probe on the level of the umbilicus and
the needle was advanced to the posterior rectus sheath,
and 10 mL of levobupivacaine was administered.
The surgical procedure itself was uneventful, and re-
covery was satisfactory. The operation duration was
289 min, and the anesthesia duration was 406 min. The
blood loss was 222 mL, and the urinary output was
1250 mL. The patient received 3600 mL of fluid admin-
istration. The patient reported no pain at the surgical
site after extubation. Postoperative supplemental analge-
sics were administered. The patients received intraven-
ous flurbiprofen axetil and acetaminophen on the first
postoperative day. After started oral intake, loxoprofen
sodium was administered and reported no pain.
After the surgery, thin, watery-pink exudate was seen
from surgical drain, but on the seventh postoperative
day, the color of the fluid changed to have a moreslightly reddish consistency. Although amount of exud-
ate from the surgical drain did not increase, the drain
was removed on the same day. The levels of exudate
from the surgical drain after surgery are shown in
Table 2. Coagulation tests were performed every day
after the surgery. The PT and PT-INR levels were nor-
mal throughout the perioperative period. The periopera-
tive APTT levels are shown in Fig. 1.Discussion
Factor XI deficiency, which is relatively common among
Ashkenazi Jews, is associated with injury-related bleed-
ing [3]. This is sometimes called “hemophilia C,” is dis-
tinguished from hemophilia A and B by the absence of
hemorrhage inside joints and muscles, and has equal in-
cidence in individuals of either gender. The level of the
deficiency does not determine the bleeding risk [4], and
bleeding tendency varies among individuals. Patients
who have severe factor XI deficiency are at risk of
massive hemorrhage; however, some do not have this
tendency [5].
Patients with factor XI deficiency need specific man-
agement during surgery. Previously, adverse surgical out-
comes of patients with factor XI deficiency have been
reported, including cerebral hemorrhage [6] and spinal
epidural hematoma [7]. Different surgical management
strategies, each with varying degrees of risk, have been
reported, including FFP, factor XI concentrates, and des-
mopressin [8].
To manage hemorrhage tendency during the peri-
operative period, anesthesiologists must determine an
appropriate method and tailor it to each patient. We
used 4 units of FFP prior to the surgical procedure. The
estimated half-life of factor XI is 45 h, which is similar
to standard FFP [9]; therefore, we judged FFP transfu-
sion 1 day prior to surgery which would prevent intraop-
erative and acute phase massive hemorrhage. As shown
in Fig. 1, APTT levels improved from 89.7 to 36.2 s after
FFP transfusion. We investigated the transition level of
APTT after surgery. The level of APTT was gradually
prolonged to 52.6 s by postoperative day 7. After the
surgery, the color of the exudate fluid from surgical
drain had changed to slightly reddish, which may have
been related to the change of APTT. Considering the es-
timated half-life of factor XI, we anticipated that APTT
would rise to the same level as the preoperative value.
Fortunately, APTT remained shorter than expected, and
we did not need to use additional FFP.
Fig. 1 Perioperative activated partial thromboplastin time (APTT)
levels. FFP fresh frozen plasma, POD postoperative day
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volumes are required and the potential for allergic re-
actions and infections. The patient described in our
case report had no cardiac disease, and only 4 units
of FFP were used, so fluid overload was not an issue;
however, FFPs should be transfused carefully, espe-
cially in patients who have cardiac failure. Although
factor XI concentrates are an effective treatment, they
are not currently available in Japan.
In addition to medication, safe and reliable anesthesia
is required to manage perioperative hemorrhage. Epi-
dural anesthesia is one of the most useful methods to
alleviate surgical pain during the perioperative period.
Although the incidence of neurologic dysfunction
resulting from hemorrhagic complication associated
with neuraxial blockade, including epidural anesthesia,
is unknown [10], the risk of bleeding is increased, espe-
cially in the presence of coagulopathy. In recent years,
peripheral nerve blocks using ultrasound have gained
popularity. It serves as an effective alternative analgesia
when an epidural is contraindicated or refused. Although
guidelines for regional anesthesia in the patient receiving
anticoagulants are available, regional anesthesia for pa-
tients with a clotting factor deficiency is dependent on the
careful decision-making by the attending anesthesiologist.
In this case, we opted to avoid the potential risk of a spinal
hematoma associated with epidural anesthesia and de-
cided to control perioperative pain using a peripheral
nerve block. Subcostal TAP block provides analgesia in
the upper abdominal area [11], and combined with a
rectus sheath block that provides effective pain relief
for the umbilical are, we were able to alleviate pain
in our patient. Neurologic dysfunctions after epidural
anesthesia are very rare but devastating. Appropriatemanagement for patients with clotting factor defi-
ciency should result in an uneventful recovery.
Conclusions
In conclusion, although factor XI deficiency is rare, it is
sometimes diagnosed by unsuspecting patients prior to
major surgery. Massive hemorrhage occurs unpredict-
ably during perioperative period regardless of the
bleeding tendency before surgery. FFP transfusion prior
to surgery may help patients’ coagulation, and proper
anesthetic management, including peripheral nerve
block, may contribute to improved prognosis.
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